Rna Sequencing Market

Rna Sequencing Market

RNA Sequencing Market Forecasts to 2030 - Global Analysis By Product (Instruments, Reagents & Kits and Other Products), Service (RNA Sequencing Platforms & Consumables, Data Analysis, RNA Sequencing Services, Storage And Management and Other Services), Technology, Application, End User and By Geography

4.0 (68 reviews)
4.0 (68 reviews)
Published: 2023 ID: SMRC24391

This report covers the impact of COVID-19 on this global market

Years Covered


CAGR (2023 - 2030)


Regions Covered

North America, Europe, Asia Pacific, South America, and Middle East & Africa

Countries Covered

US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa

Largest Market

Asia Pacific

Highest Growing Market

North America

According to Stratistics MRC, the Global RNA Sequencing Market is growing at a CAGR of 21.4% during the forecast period. RNA sequencing, also known as RNA-Seq, is a genomic approach for the detection and quantitative analysis of messenger RNA molecules in a biological sample and is useful for studying cellular responses. RNA sequencing uses the capabilities of high-throughput sequencing methods to provide insight into the transcriptome of a cell. This method is crucial for studying gene expression patterns, understanding cellular processes, identifying biomarkers, and exploring disease mechanisms in various research areas, including genetics, genomics, molecular biology, and medicine.

According to Rare Diseases International, and EURORDIS, rare diseases currently affect at any point in time 3.5% - 5.9% of the worldwide population; 72% are genetic, of which around 70% start in childhood.

Market Dynamics: 


Growing demand for precision medicine

RNA sequencing plays a crucial role in precision medicine by enabling comprehensive analysis of an individual's genetic information at the molecular level. Identification of particular genetic variants, patterns of gene expression and genetic markers that impact the susceptibility to disease, its progression, and its response to treatment are rendered easier by it. This comprehensive knowledge makes it possible to implement individualised healthcare interventions, such as targeted therapies and therapies based on a person's genetic profile. Moreover, the capacity of RNA sequencing to interpret complex genetic data has become increasingly essential as precision medicine gains pace. This will encourage the integration of RNA sequencing into clinical care and research, which will fuel market growth for RNA sequencing.


Data analysis challenges

Data analysis complexities pose a restraint in the RNA sequencing market due to the immense data volume and intricacies involved. Analysing RNA sequencing data demands advanced computational infrastructure, specialised algorithms, and bioinformatics expertise to interpret gene expression patterns accurately. Standardising analysis methods across platforms for result consistency is challenging, impacting data reliability. A shortage of skilled analysts and evolving tools further complicate the process. Therefore, it will limit market demand.


Innovation in bioinformatics

Advancements in bioinformatics tools and algorithms enable more sophisticated analysis, interpretation, and visualisation of complex RNA sequencing data. These innovations enhance data accuracy, facilitate the identification of gene expression patterns, splice variants, and non-coding RNAs, and empower researchers to extract meaningful biological insights. Furthermore, improved software solutions streamline data processing, making analysis more accessible to a wider range of users. Continual bioinformatics innovation also drives the development of novel analytical methods, fostering deeper understanding and application of RNA sequencing in diverse research fields, clinical diagnostics, and drug development.


Data security and privacy concerns

The exponential growth in genomic data raises apprehensions about unauthorised access, misuse, and breaches of sensitive genetic information. As RNA sequencing generates extensive personal genetic profiles, ensuring the confidentiality and secure handling of this data becomes paramount. Potential risks include unauthorised data access, identity breaches, and ethical dilemmas related to sharing genomic information. These concerns could erode public trust, resulting in regulatory restrictions on data sharing and utilization.

Covid-19 Impact

The COVID-19 pandemic had a significant impact on the RNA sequencing market. Despite the initial hurdles imposed by disrupted supply chains and restricted laboratories, demand for RNA sequencing quickly increased. Researchers accelerated genomic studies to understand the virus, develop vaccines, and identify potential treatments. The industry witnessed an evolution in the direction of automated and remote solutions to lessen operational difficulties. Furthermore, the pandemic underscored the significance of RNA sequencing in the investigation of infectious diseases, cancer, and personalised medicine, hence promoting sustained expansion and variety in the market's applications and solutions.

The Ion Semiconductor Sequencing segment is expected to be the largest during the forecast period

The Ion Semiconductor Sequencing segment is estimated to hold the largest share. Ion semiconductor sequencing is a technique for sequencing DNA that relies on the identification of hydrogen ions generated during DNA polymerization. This method involves detecting changes in pH levels generated as nucleotides are incorporated into a growing DNA strand. Sequencing from Ion Semiconductor is renowned for its quick processing, affordability, and fit for specific sequencing applications. Additionally, it can precisely identify DNA sequences by measuring changes in ion concentrations, making RNA analysis for gene expression research, variant detection, and comprehending biological processes possible. 

The Academic and Research Institutes segment is expected to have the highest CAGR during the forecast period

The Academic and Research Institutes segment is anticipated to have lucrative growth during the forecast period. The Academic and Research Institutes comprise educational institutions, universities, and research organisations actively engaged in scientific investigations and genomic studies. These entities play a pivotal role in advancing RNA sequencing technologies by conducting fundamental research, exploring novel applications, and validating sequencing methodologies. They leverage RNA sequencing for diverse purposes, including deciphering gene expression patterns, identifying biomarkers, understanding disease mechanisms, and developing therapeutic interventions. Thus, there is an increasing demand for segment growth.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to rising adoption of precision medicine, government initiatives supporting genomics research, and a surge in collaborations among academic institutions and biotech firms. Factors like reduced sequencing costs, expanding applications in clinical diagnostics, and the presence of key market players are driving market growth. With growing demand for personalised medicine and advancements in bioinformatics, the Asia-Pacific RNA sequencing market is poised for continuous expansion and innovation, shaping the future of healthcare and biological research in the region. 

Region with highest CAGR: 

North America is expected to witness profitable growth over the projection period, owing to the rising acceptance for RNA sequencing techniques. It is characterised by extensive research initiatives, robust funding, and a favourable regulatory landscape. Factors such as increasing investments in genomics research, collaborations between academic institutions and industry players, and the prominence of precision medicine drive market growth. The high demand for RNA sequencing in drug discovery, diagnostics, and personalised medicine, along with advancements in sequencing techniques and data analysis tools, propels the market forward.

Key players in the market

Some of the key players in the RNA Sequencing Market include Thermo Fischer Scientific, Illumina, Tecan Genomics Inc., Agilent Technologies Inc., F. Hoffmann-La Roche Ltd, PerkinElmer Inc., GE Healthcare, Bio-Rad Laboratories Inc., Eurofins Scientific, Sigma Aldrich, Admera Health, CD Genomics, Biogazelle, Creative Biogene, LC Sciences, IGA Technology , Lexogen, Otogenetics, Novogene, Yaazh Xenomic and Oxford Nanopore Technologies.

Key Developments:

In August 2023, Thermo Fisher Scientific, the world leader in serving science, announced the launch of a new chromosomal microarray designed to improve cytogenetic research lab productivity, efficiency and profitability with an industry-leading two-day turnaround time. 

In May 2023, Thermo Fisher Scientific, the world leader in serving science, expanded its manufacturing capacity in St. Louis to support biologic therapies for diseases ranging from cancers to auto immune conditions to rare genetic disorders.

In March 2021, Thermo Fisher Scientific Inc., declared the introduction of the Thermo Scientific Aerosol Sense Sampler, a novel surveillance solution planned to transfer speedy and greatly trustworthy insight into the existence of in-air pathogens, inclusive of SARS-CoV-2. Individual testing will persist in being essential in the COVID-19 pandemic response owing to its ability to allow and apprise clinical diagnoses, patient triage, and treatment decisions. 

Products Covered:
• Instruments 
• Reagents & Kits 
• Other Products 

Services Covered:
• RNA Sequencing Platforms & Consumables 
• Data Analysis 
• RNA Sequencing Services 
• Storage And Management 
• Other Services 

Technologies Covered:
• Sequencing by Synthesis
• Nanopore Sequencing 
• Single Molecule Real Time Sequencing 
• Ion Semiconductor Sequencing 
• Other Technologies 

Applications Covered:
• Expression Profiling Analysis
• Small RNA Sequencing 
• De Novo Transcriptome Assembly 
• Variant Calling 
• Personalized Medicine 
• Other Applications
End Users Covered:
• Hospitals and Diagnostic Centers
• Pharmaceutical & Biotechnology Companies
• Academic and Research Institutes
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan        
o China        
o India        
o Australia  
o New Zealand
o South Korea
o Rest of Asia Pacific    
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa 
o Saudi Arabia
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings: 
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary       
2 Preface        
 2.1 Abstract       
 2.2 Stake Holders      
 2.3 Research Scope      
 2.4 Research Methodology     
  2.4.1 Data Mining     
  2.4.2 Data Analysis     
  2.4.3 Data Validation     
  2.4.4 Research Approach     
 2.5 Research Sources      
  2.5.1 Primary Research Sources    
  2.5.2 Secondary Research Sources    
  2.5.3 Assumptions     
3 Market Trend Analysis      
 3.1 Introduction      
 3.2 Drivers       
 3.3 Restraints      
 3.4 Opportunities      
 3.5 Threats       
 3.6 Product Analysis      
 3.7 Technology Analysis     
 3.8 Application Analysis     
 3.9 End User Analysis      
 3.10 Emerging Markets      
 3.11 Impact of Covid-19      
4 Porters Five Force Analysis      
 4.1 Bargaining power of suppliers     
 4.2 Bargaining power of buyers     
 4.3 Threat of substitutes     
 4.4 Threat of new entrants     
 4.5 Competitive rivalry      
5 Global RNA Sequencing Market, By Product    
 5.1 Introduction      
 5.2 Instruments      
 5.3 Reagents & Kits      
 5.4 Other Products      
6 Global RNA Sequencing Market, By Services    
 6.1 Introduction      
 6.2 RNA Sequencing Platforms & Consumables   
 6.3 Data Analysis      
 6.4 RNA Sequencing Services     
 6.5 Storage And Management     
 6.6 Other Services      
7 Global RNA Sequencing Market, By Technology    
 7.1 Introduction      
 7.2 Sequencing by Synthesis     
 7.3 Nanopore Sequencing     
 7.4 Single Molecule Real Time Sequencing    
 7.5 Ion Semiconductor Sequencing    
 7.6 Other Technologies      
8 Global RNA Sequencing Market, By Application    
 8.1 Introduction      
 8.2 Expression Profiling Analysis     
 8.3 Small RNA Sequencing     
 8.4 De Novo Transcriptome Assembly    
 8.5 Variant Calling      
 8.6 Personalized Medicine     
 8.7 Other Applications      
9 Global RNA Sequencing Market, By End User    
 9.1 Introduction      
 9.2 Hospitals and Diagnostic Centers    
 9.3 Pharmaceutical & Biotechnology Companies   
 9.4 Academic and Research Institutes    
 9.5 Other End Users      
10 Global RNA Sequencing Market, By Geography    
 10.1 Introduction      
 10.2 North America      
  10.2.1 US      
  10.2.2 Canada      
  10.2.3 Mexico      
 10.3 Europe       
  10.3.1 Germany      
  10.3.2 UK      
  10.3.3 Italy      
  10.3.4 France      
  10.3.5 Spain      
  10.3.6 Rest of Europe     
 10.4 Asia Pacific      
  10.4.1 Japan      
  10.4.2 China      
  10.4.3 India      
  10.4.4 Australia      
  10.4.5 New Zealand     
  10.4.6 South Korea     
  10.4.7 Rest of Asia Pacific     
 10.5 South America      
  10.5.1 Argentina     
  10.5.2 Brazil      
  10.5.3 Chile      
  10.5.4 Rest of South America    
 10.6 Middle East & Africa     
  10.6.1 Saudi Arabia     
  10.6.2 UAE      
  10.6.3 Qatar      
  10.6.4 South Africa     
  10.6.5 Rest of Middle East & Africa    
11 Key Developments       
 11.1 Agreements, Partnerships, Collaborations and Joint Ventures  
 11.2 Acquisitions & Mergers     
 11.3 New Product Launch     
 11.4 Expansions      
 11.5 Other Key Strategies     
12 Company Profiling       
 12.1 Thermo Fischer Scientific     
 12.2 Illumina, Tecan Genomics Inc.     
 12.3 Agilent Technologies Inc.     
 12.4 F. Hoffmann-La Roche Ltd     
 12.5 PerkinElmer Inc.      
 12.6 GE Healthcare      
 12.7 Bio-Rad Laboratories Inc.     
 12.8 Eurofins Scientific      
 12.9 Sigma Aldrich      
 12.10 Admera Health      
 12.11 CD Genomics      
 12.12 Biogazelle      
 12.13 Creative Biogene      
 12.14 LC Sciences      
 12.15 IGA Technology      
 12.16 Lexogen       
 12.17 Otogenetics      
 12.18 Novogene      
 12.19 Yaazh Xenomic      
 12.20 Oxford Nanopore Technologies    
List of Tables        
1 Global RNA Sequencing Market Outlook, By Region (2021-2030) ($MN)  
2 Global RNA Sequencing Market Outlook, By Product (2021-2030) ($MN)  
3 Global RNA Sequencing Market Outlook, By Instruments (2021-2030) ($MN) 
4 Global RNA Sequencing Market Outlook, By Reagents & Kits (2021-2030) ($MN) 
5 Global RNA Sequencing Market Outlook, By Other Products (2021-2030) ($MN) 
6 Global RNA Sequencing Market Outlook, By Services (2021-2030) ($MN)  
7 Global RNA Sequencing Market Outlook, By RNA Sequencing Platforms & Consumables (2021-2030) ($MN)
8 Global RNA Sequencing Market Outlook, By Data Analysis (2021-2030) ($MN) 
9 Global RNA Sequencing Market Outlook, By RNA Sequencing Services (2021-2030) ($MN)
10 Global RNA Sequencing Market Outlook, By Storage And Management (2021-2030) ($MN)
11 Global RNA Sequencing Market Outlook, By Other Services (2021-2030) ($MN) 
12 Global RNA Sequencing Market Outlook, By Technology (2021-2030) ($MN) 
13 Global RNA Sequencing Market Outlook, By Sequencing by Synthesis (2021-2030) ($MN)
14 Global RNA Sequencing Market Outlook, By Nanopore Sequencing (2021-2030) ($MN)
15 Global RNA Sequencing Market Outlook, By Single Molecule Real Time Sequencing (2021-2030) ($MN)
16 Global RNA Sequencing Market Outlook, By Ion Semiconductor Sequencing (2021-2030) ($MN)
17 Global RNA Sequencing Market Outlook, By Other Technologies (2021-2030) ($MN) 
18 Global RNA Sequencing Market Outlook, By Application (2021-2030) ($MN) 
19 Global RNA Sequencing Market Outlook, By Expression Profiling Analysis (2021-2030) ($MN)
20 Global RNA Sequencing Market Outlook, By Small RNA Sequencing (2021-2030) ($MN)
21 Global RNA Sequencing Market Outlook, By De Novo Transcriptome Assembly (2021-2030) ($MN)
22 Global RNA Sequencing Market Outlook, By Variant Calling (2021-2030) ($MN) 
23 Global RNA Sequencing Market Outlook, By Personalized Medicine (2021-2030) ($MN)
24 Global RNA Sequencing Market Outlook, By Other Applications (2021-2030) ($MN) 
25 Global RNA Sequencing Market Outlook, By End User (2021-2030) ($MN)  
26 Global RNA Sequencing Market Outlook, By Hospitals and Diagnostic Centers (2021-2030) ($MN)
27 Global RNA Sequencing Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
28 Global RNA Sequencing Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
29 Global RNA Sequencing Market Outlook, By Other End Users (2021-2030) ($MN) 
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

List of Figures


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.

Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.

For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.


Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.